Cargando…

Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity

Detalles Bibliográficos
Autores principales: Chen, Qiang, Yan, Yan, Yang, Chuanping, Liu, Guangjun, Wang, Gaoming, Li, Si, Chen, Dongsheng, Xiao, Mingzhe, Wu, Yanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339741/
https://www.ncbi.nlm.nih.gov/pubmed/34422387
http://dx.doi.org/10.21037/jtd-21-689
_version_ 1783733653888565248
author Chen, Qiang
Yan, Yan
Yang, Chuanping
Liu, Guangjun
Wang, Gaoming
Li, Si
Chen, Dongsheng
Xiao, Mingzhe
Wu, Yanmin
author_facet Chen, Qiang
Yan, Yan
Yang, Chuanping
Liu, Guangjun
Wang, Gaoming
Li, Si
Chen, Dongsheng
Xiao, Mingzhe
Wu, Yanmin
author_sort Chen, Qiang
collection PubMed
description
format Online
Article
Text
id pubmed-8339741
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-83397412021-08-20 Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity Chen, Qiang Yan, Yan Yang, Chuanping Liu, Guangjun Wang, Gaoming Li, Si Chen, Dongsheng Xiao, Mingzhe Wu, Yanmin J Thorac Dis Letter to the Editor AME Publishing Company 2021-07 /pmc/articles/PMC8339741/ /pubmed/34422387 http://dx.doi.org/10.21037/jtd-21-689 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Chen, Qiang
Yan, Yan
Yang, Chuanping
Liu, Guangjun
Wang, Gaoming
Li, Si
Chen, Dongsheng
Xiao, Mingzhe
Wu, Yanmin
Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
title Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
title_full Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
title_fullStr Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
title_full_unstemmed Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
title_short Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
title_sort chr1 95026203-alk, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339741/
https://www.ncbi.nlm.nih.gov/pubmed/34422387
http://dx.doi.org/10.21037/jtd-21-689
work_keys_str_mv AT chenqiang chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT yanyan chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT yangchuanping chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT liuguangjun chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT wanggaoming chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT lisi chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT chendongsheng chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT xiaomingzhe chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity
AT wuyanmin chr195026203alkanovelintergenicfusionidentifiedinapatientwithlungadenocarcinomawithnodulargroundglassopacity